Now, Scripps Research scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that target it. Their research, published in Nature ...

1 RSV remains a significant burden primarily due ... Standard laboratory instrumentation and methodologies were used to analyze protein structure conformation. Size-exclusion chromatography ...

Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials for any of the target populations. High levels of neutralizing antibodies to RSV F protein have ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna.

The RSV (Respiratory syncytial virus) jab was given for the first time in Scotland last August. Research by Public Health Scotland (PHS), published in The Lancet Infectious Diseases Journal ...